Authors' reply Dear Editors, Neutrophil-to-lymphocyte ratio varies with patient age and body mass index. 1 Therefore, in our study, there was no difference between the body mass indices and mean ages of the groups ( p = 0.20 and p = 0.415 respectively). The neutrophil-to-lymphocyte ratio is now accepted as a significant predictor of adverse clinical outcomes, and various studies have found neutrophil-to-lymphocyte ratio to be a reliable biomarker in oncology, 2,3 cardiology, 4,5 and several other diseases accompanied by systemic inflammation such as Alzheimer's disease, ulcerative colitis, appendicitis and chronic kidney disease.
6-9 The standard cut-off value of neutrophil-to-lymphocyte ratio was not stated in these studies either. These studies compared the groups as we did in our study. The cut-off values of neutrophils and lymphocytes are known. A meta-analysis of the studies covering neutrophil-to-lymphocyte ratio would need to be conducted to define a standard cut-off value of neutrophil-tolymphocyte ratio.
Neutrophil-to-lymphocyte ratio has started to be used in systemic inflammatory diseases, including those that implicate interleukin (IL)-6, IL-10, IL-1α, tumour necrosis factor-α and other inflammatory cytokines.
10-12 Moreover, it may show variability in inflammatory conditions, as do other cytokines. For this reason, more studies have been conducted in recent years examining the association of neutrophil-to-lymphocyte ratio with inflammation. [1] [2] [3] [4] [5] [6] [7] [8] [9] The results of our study demonstrated that the neutrophilto-lymphocyte ratio values had a positive correlation with the severity of obstructive sleep apnoea syndrome (OSAS). 
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